CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Big Deal
Geopolitical Shock Wave: Latest M&A Delays Tied to Volatility in the Middle East
The tentative rebound in global Mergers & Acquisitions activity, which gained footing in the latter half of 2025, is now encountering significant headwinds driven by the escalating military conflict involving Iran. For dealmakers navigating an...
Netflix Re-Engages in Strategic M&A, Acquiring Ben Affleck’s AI Firm InterPositive
By A Wall Street Journal Reporter | Published March 5, 2026 Netflix has quietly re-entered the strategic acquisition arena, announcing the purchase of InterPositive, an artificial-intelligence filmmaking technology company founded by Academy...
Pentagon Anchors $150M Maritime Tech VC Fund, Signaling Intensified Focus on Dual-Use National Security Investments
The Department of Defense (DoD) is significantly deepening its engagement with the U.S. venture capital ecosystem, marking a renewed push to shepherd capital toward technologies deemed critical for national security. The latest data points toward a...
TPG Explores $7.6 Billion Exit for Asia OneHealthcare, Signaling Maturity in Southeast Asian Healthcare Buyouts
Private equity giant TPG is weighing strategic options for its Southeast Asian healthcare portfolio company, Asia OneHealthcare, including a potential sale or an initial public offering (IPO) that could fetch an enterprise valuation near 30 billion...
Akio Toyoda Secures Legacy in ¥6.7 Trillion Buyout, Reshaping Toyota Group Structure
In a landmark corporate maneuver testing the boundaries of Japan's evolving corporate governance landscape, the Toyota Group, led by Chairman Akio Toyoda, has successfully orchestrated the privatization of its founding entity, Toyota Industries...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Servier Clinches Day One Biopharma for $2.5 Billion, Solidifying Rare Oncology Foothold
French pharmaceutical giant Servier has moved decisively to bolster its targeted therapy pipeline, announcing a definitive agreement to acquire Day One Biopharmaceuticals (NASDAQ: DAWN) in an all-cash transaction valued at approximately \$2.5...
Sanofi Divests Brazilian Generics Unit Medley to EMS in Strategic Exit
Paris-headquartered pharmaceutical giant Sanofi has agreed to divest its Brazilian generics unit, Medley, to local drugmaker EMS, in a move signaling further streamlining of its global portfolio and a calculated retreat from non-core assets in...
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to expand beyond injectable GLP-1 therapies like Wegovy. ...
GSK Secures Potential ‘Multi-Blockbuster’ Drug in $950 Million 35Pharma Acquisition
null GlaxoSmithKline announced today that it has acquired 35Pharma Inc., a Montreal-based clinical-stage biopharmaceutical company, for $950 million in cash. The deal grants GSK access to HS235, an investigational activin signaling inhibitor...
Danaher’s $9.9 Billion Masimo Acquisition Signals Consolidation in Patient Monitoring Technology
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the medical device sector focused on acute care...
